Sharechat Logo

Volpara Health Technologies exceeds annual recurring revenue goal

Tuesday 3rd April 2018

Text too small?

Volpara Health Technologies, the Kiwi digital health firm listed on the ASX, said it exceeded its goal of lifting annual recurring revenue 200 percent for the financial year ended March 31.


Wellington-based Volpara, which focuses on early detection of breast cancer using artificial intelligence, said in a statement to the Australian stock exchange that its ARR now stands at $3.6 million. That's compared to $1.1 million at the end of FY2017, an increase of 223 percent.


ARR is the normalised amount of cash reasonably expected to be booked for the next 12 months based on the contracts signed previously, and assuming installation upon order, according to Volpara. Its total contract value - or the value of contracts signed in the specified period  - exceeded $11.2 million, up 173 percent on the prior year's $4.1 million.


The company also said that approximately 3.2 percent of all women screened in the US are now contracted to Volpara’s software (approximately 1.27 million women), compared to the target for the year of 3 percent. 


"We are just scratching the surface of the market in the US, but the signs are very encouraging," said Volpara chief executive Ralph Highnam. 


The ASX-listed shares rose 5.6 percent to 76 Australian cents.



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

New director of Vital Healthcare’s manager unfazed by fire-at-will clause
QMS pulls out A$35M from NZ unit in MediaWorks merger
Take care to avoid
Is this the calm before a storm of credit card thrashing?
Shrinking meat and dairy product manufacturing weighs on growth outlook
Jon Macdonald to stay on as Trade Me boss through takeover tussle
Shareholders’ Association wants Finzsoft to come clean
A2 rings in more executive changes under new CEO Hrdlicka
NZ dollar dips as China-US trade tensions cast pall over global markets
No end in sight to global market turmoil

IRG See IRG research reports